Milan Slavik

1.7k total citations
46 papers, 1.3k citations indexed

About

Milan Slavik is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Milan Slavik has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Milan Slavik's work include Drug Transport and Resistance Mechanisms (6 papers), Cancer Treatment and Pharmacology (5 papers) and Synthesis and Biological Evaluation (4 papers). Milan Slavik is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Cancer Treatment and Pharmacology (5 papers) and Synthesis and Biological Evaluation (4 papers). Milan Slavik collaborates with scholars based in United States, South Africa and Malaysia. Milan Slavik's co-authors include Stephen K. Carter, Daniel D. Von Hoff, Marcel Rozencweig, Franco M. Muggia, Maxwell W. Layard, Todd H. Wasserman, Sewa S. Legha, Michael Goldsmith, Christopher M. Riley and Steve Dahlberg and has published in prestigious journals such as The Lancet, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Milan Slavik

45 papers receiving 1.2k citations

Peers

Milan Slavik

ONCOL

CCM

PRM

DERMA

Tina Colombo Italy

Luigi Lenaz Germany

Ina Ifrim United States

Robert H. Liss United States

Vincent T. Oliverio United States

Robert H. Earhart United States

Elena Strocchi Italy

Peter Buhl Jensen Denmark

Bach Ardalan United States

Steven D. Reich United States

Tina Colombo Italy

Milan Slavik

910 ×1.8

ONCOL

737 ×2.1

187 ×0.6

CCM

295 ×1.8

PRM

37 ×0.2

DERMA

Citations per year, relative to Milan Slavik Milan Slavik (= 1×) peers Tina Colombo

Countries citing papers authored by Milan Slavik

Since Specialization

Citations

This map shows the geographic impact of Milan Slavik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milan Slavik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milan Slavik more than expected).

Fields of papers citing papers by Milan Slavik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milan Slavik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milan Slavik. The network helps show where Milan Slavik may publish in the future.

Co-authorship network of co-authors of Milan Slavik

This figure shows the co-authorship network connecting the top 25 collaborators of Milan Slavik. A scholar is included among the top collaborators of Milan Slavik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milan Slavik. Milan Slavik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Slavik, Milan, et al.. (1998). Plasma analysis of α-difluoromethylornithine using pre-column derivatization with naphthalene-2,3-dicarboxaldehyde/CN and multidimensional chromatography. Journal of Pharmaceutical and Biomedical Analysis. 17(6-7). 1205–1213. 19 indexed citations

Slavik, Milan, et al.. (1995). Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. Investigational New Drugs. 13(2). 143–147. 3 indexed citations

Wilson, George S., et al.. (1994). Pharmacokinetic studies of α-difluoromethylornithine in rabbits using an enzyme-linked immunosorbent assay. Journal of Pharmaceutical and Biomedical Analysis. 12(10). 1249–1257. 10 indexed citations

Slavik, Milan, Kenneth J. Kopecky, Vernon K. Sondak, John B. Craig, & Michael K. Samson. (1993). Evaluation of amonafide in disseminated malignant melanoma. Investigational New Drugs. 11(2-3). 223–226. 5 indexed citations

Shetty, Bhasker V., et al.. (1992). Degradation of dacarbazine in aqueous solution. Journal of Pharmaceutical and Biomedical Analysis. 10(9). 675–683. 34 indexed citations

Fabian, Carol J., R Molina, Milan Slavik, et al.. (1990). Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational New Drugs. 8(1). 57–63. 100 indexed citations

Stobaugh, John F., et al.. (1990). Stereoselective pharmacokinetics and metabolism of the enantiomers of cyclophosphamide. Biochemical Pharmacology. 39(8). 1375–1384. 17 indexed citations

Riley, Christopher M., et al.. (1989). Analysis of 5-flourouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography. Journal of Chromatography A. 473(2). 431–444. 16 indexed citations

Slavik, Milan, et al.. (1989). Changes in Serum Copper and Zinc During Treatment With Anticancer Drugs Interfering With Pyridoxal Phosphate. PubMed. 258. 235–242. 1 indexed citations

10.

Slavik, Milan, Joachim Hermann, G. D. Carlyle Thompson, et al.. (1987). Phase I trial and pharmacokinetic study of intravenous and oral α-Difluoromethylornithine. Investigational New Drugs. 5(2). 177–186. 22 indexed citations

11.

Slavik, Milan & Joseph H. Saiers. (1983). Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.. PubMed. 10(1 Suppl 1). 62–5. 18 indexed citations

12.

Slavik, Milan, et al.. (1982). Phase II studies in advanced, recurrent pelvic malignancies. American Journal of Clinical Oncology. 5(5). 483–486. 3 indexed citations

13.

Hoff, Daniel D. Von & Milan Slavik. (1977). 5-Azacytidine—A New Anticancer Drug with Significant Activity in Acute Myeloblastic Leukemia. Advances in pharmacology. 14. 285–326. 26 indexed citations

14.

Legha, Sewa S., Milan Slavik, & Stephen K. Carter. (1976). Nafoxidine–-an antiestrogen for the treatment of breast cancer. Cancer. 38(4). 1535–1541. 32 indexed citations

15.

Legha, Sewa S., Milan Slavik, & Stephen K. Carter. (1976). Hexamethylmelamine.An evaluation of its role in the therapy of cancer. Cancer. 38(1). 27–35. 70 indexed citations

16.

Goldsmith, Michael, et al.. (1975). Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.. PubMed. 35(5). 1354–64. 90 indexed citations

17.

Wasserman, Todd H., Milan Slavik, & Stephen K. Carter. (1975). Clinical comparison of the nitrosoureas. Cancer. 36(4). 1258–1268. 84 indexed citations

18.

Wasserman, Todd H., Milan Slavik, & Stephen K. Carter. (1974). Review of CCNU in clinical cancer therapy. Cancer Treatment Reviews. 1(2). 131–151. 47 indexed citations

19.

Slavik, Milan, et al.. (1973). Alterations in metabolism of copper and zinc after administration of 6-azauridine triacetate. Biochemical Pharmacology. 22(18). 2349–2352. 6 indexed citations

20.

Slavik, Milan, Harry R. Keiser, Walter Lovenberg, & Albert Sjoerdsma. (1971). Hyperaminoacidemia in rabbits treated with 6-azauridine triacetate. Life Sciences. 10(22). 1293–1295. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact